Khaled Harb is a distinguished pharmaceutical leader with over 30 years of experience in leading multinational companies across the Middle East, North Africa, Eastern Europe, and Saudi Arabia. Since his appointment as Chief Executive Officer of Dar Aldawa for Development and Investment in 2022, he has played a pivotal role in reinforcing the company’s position as one of the region’s most trusted pharmaceutical companies.

Mr. Harb holds an Executive MBA from the American University of Beirut and a Bachelor’s degree in Pharmacy and Pharmaceutical Sciences from the Medical Academy in Sofia, Bulgaria. He also serves on the boards of Nutridar and Dar Aldawa for Veterinary and Agricultural Industries and is Vice Chairman of the Jordanian Association of Pharmaceutical Manufacturers, where he actively promotes regulatory excellence, sustainability, and the advancement of Jordan’s pharmaceutical industry.